Related Experiment Video
Updated: Mar 29, 2026
06:48
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
22.4K
AAV2-Retro-Mediated Gene Transfer Selectively Targets Outer Retinal Cells Following Intravitreal Injection
Chaimaa Kinane1, Moxa Panchal1, Pantelis Tsoulfas2
1Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Investigative Ophthalmology & Visual Science
|March 27, 2026
Summary
Adeno-associated virus 2 (AAV2)-retro enables efficient, outer retina gene delivery via intravitreal injection. This method targets photoreceptors and RPE cells, offering a less invasive alternative for retinal gene therapy.
Area of Science:
- Ophthalmology
- Gene Therapy
- Molecular Biology
Background:
- Intravitreal gene delivery is crucial for treating retinal diseases.
- Conventional adeno-associated virus (AAV) vectors often require subretinal injection for effective outer retinal targeting.
- Developing minimally invasive gene delivery methods is essential for advancing retinal therapies.
Purpose of the Study:
- To characterize the cellular tropism and temporal dynamics of adeno-associated virus 2 (AAV2)-retro-mediated gene delivery.
- To evaluate AAV2-retro gene delivery following intravitreal injection in the adult mouse retina.
- To assess the efficiency and specificity of AAV2-retro for targeting retinal cells.
Main Methods:
- Adult C57BL/6J mice received intravitreal injections of AAV2-retro carrying the mGreenLantern (mGL) reporter gene.
- Retinas were collected at 1, 3, and 14 days post-injection for immunofluorescence analysis.
- Transduced cell types were identified using specific cell markers; transduction efficiency and distribution were quantified.
Main Results:
- AAV2-retro showed strong tropism for photoreceptors and retinal pigment epithelium (RPE), including rods and cones.
- Reporter expression was detected early (1 day post-injection) and increased over time.
- Gene delivery was primarily in the outer retina, with limited transduction in inner retinal layers, demonstrating cell-type specificity.
- Intravitreal AAV2-retro achieved wider retinal coverage than conventional AAV2 subretinal delivery.
- Sequential injections enhanced reporter expression and spatial coverage.
Conclusions:
- AAV2-retro facilitates efficient and outer retina-specific gene delivery via intravitreal administration.
- This approach presents a minimally invasive alternative to subretinal injections for retinal gene transfer.
- AAV2-retro holds promise for preclinical studies of retinal degeneration and gene therapies targeting photoreceptor and RPE function.
